According to Newbury Pharmaceuticals AB latest financial reports the company has an operating margin of -1.68%, an decrease of -25.26% to 2022. At the end of 2022 company had an operating margin of -2.24%.
Year | Operating Margin | Change |
---|---|---|
2023 | -1.68% | -25.26% |
2022 | -2.24% | 12.94% |
2021 | -1.99% | - |